In 2021, 11 551 (15.6%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one of the ICU-acquired healthcare-associated infections (HAI) under surveillance (pneumonia, bloodstream infection or urinary tract infection).
The purpose of ECDC’s technical visits to the Western Balkans and Türkiye is to identify areas in the surveillance of communicable diseases that may require further work, and possible ECDC support.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 October 2024 and includes updates on measles, mpox, avian influenza, West Nile virus, dengue, Marburg virus disease, a new strain of multidrug-resistant Shigella Sonnei ST152, and an overview of respiratory virus epidemiology in the EU/EEA.
This focused after-action review (AAR) investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron variant was circulating and schools remained open.
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA).
ECDC is helping countries in the Western Balkans and Türkiye improve their infectious disease prevention and control systems and public health workforce. This will prepare the countries for their future participation in ECDC work.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 September - 4 October 2024 and includes updates on Marburg virus disease, Mpox, avian influenza A(H5N1) human cases, an overview of respiratory virus epidemiology in the EU/EEA, West Nile virus, dengue, SARS-CoV-2, MERS-CoV, and chikungunya.
This ECDC survey protocol describes the technical requirements for implementing a genomic surveillance-based survey of CRAb isolates from patients seeking hospital care. It is intended for first use in 2024–2025.
This technical report is a laboratory manual that accompanies the ‘Survey protocol for the ECDC genomic-based surveillance of carbapenem-resistant Acinetobacter baumannii in Europe’.